Related Experiment Videos
[Genetics of renal tumors]
1Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Altalános Orvostudományi Kar, Gyermekklinika.
Orvosi Hetilap
|August 2, 2001
Summary
Genetic alterations in renal tumors, including somatic mutations and chromosomal changes, drive malignant transformation. Understanding these molecular changes aids in diagnosis, therapy selection, and disease prevention.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Context:
- Malignant transformation of tumor progenitor cells involves genetic alterations, primarily somatic mutations.
- Renal tumors exhibit diverse chromosomal abnormalities, including losses, gains, and translocations, impacting cell proliferation and differentiation.
Purpose:
- To elucidate the genetic mechanisms underlying renal tumor development and progression.
- To correlate specific cytogenetic and molecular genetic alterations with tumor classification, diagnosis, and prognosis.
Summary:
- Renal tumors arise from genetic alterations, such as mutations in tumor suppressor genes like WT-1 in Wilms' tumor, and chromosomal aberrations in various histological types.
- Specific genetic changes, including deletions (e.g., 11p13 in Wilms' tumor, 3p in renal carcinoma) and gains (e.g., trisomies 7 and 17 in papillary carcinoma), are associated with distinct renal tumor entities.
- Genomic imprinting abnormalities (IGF2, H19) and sequential chromosomal aberrations contribute to renal carcinogenesis, supporting a multistep model.
Impact:
- Cytogenetic and molecular genetic findings confirm morphological classifications and provide insights into the relationships between different renal tumor types.
- Genetic analysis aids in accurate diagnosis, histological typing, and predicting disease progression, crucial for therapeutic decisions.
- Identifying constitutional mutations in hereditary cases allows for risk assessment and targeted prevention strategies in families.